Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy

The present study aimed to identify whether CD166 can be used as a biomarker for predicting the response of nasopharyngeal carcinoma (NPC) to radiotherapy. The serum concentration of CD166 in patients with NPC were detected by enzyme-linked immunosorbent assay. The secreted level of CD166 with radio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lin, Huan, Chen, Ze-Tan, Zhu, Xiao-Dong, Li, Ling, Qu, Song, Wei, Zhao, Su, Fang, Wei, Jing-Ni, Liang, Zhong-Guo, Mo, Qi-Yan, Wu, Jiang-Bo, Meng, Hui-Ling
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5609886/
https://ncbi.nlm.nih.gov/pubmed/28968954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16399
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados